Enzymes of the central carbon metabolism: Are they linkers between transcription, DNA replication, and carcinogenesis?

Medical Hypotheses

Volumn 84, Issue 1, 2015, Pages 58-67

  Konieczna, Aleksandra ^a   Szczepańska, Aneta ^a   Sawiuk, Karolina ^a   Łyzeń, Robert ^a   Wegrzyn, Grzegorz ^a  

^a UNIVERSITY OF GDA SK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ACONITATE HYDRATASE; ALPHA KETOGLURATE DEHYDROGENASE; CARBON; CITRATE SYNTHASE; DIPHOSPHATE ALDOLASE; DNA; DNA DIRECTED DNA POLYMERASE GAMMA; ENOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE; FUMARATE HYDRATASE; GLUCOSE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEXOKINASE; ISOCITRATE DEHYDROGENASE; LACTATE DEHYDROGENASE; MALATE DEHYDROGENASE; OXOGLUTARATE DEHYDROGENASE; PHOSPHOGLUCOMUTASE; PHOSPHOGLYCERATE KINASE; PYRUVATE KINASE; PYRUVATE KINASE M; SUCCINATE DEHYDROGENASE; SUCCINYL COENZYME A SYNTHETASE; TRICARBOXYLIC ACID; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG; ENZYME;

ARTICLE; CANCER CELL; CARBON METABOLISM; CARCINOGENESIS; CITRIC ACID CYCLE; DNA REPAIR; DNA REPLICATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; GLYCOLYSIS; MAMMAL CELL; YEAST CELL; BIOLOGICAL MODEL; HUMAN; METABOLISM; PHYSIOLOGY;

CARBON; CARCINOGENESIS; CITRIC ACID CYCLE; DNA REPLICATION; ENZYMES; GLYCOLYSIS; HUMANS; MODELS, BIOLOGICAL; TRANSCRIPTION, GENETIC;

EID: 84918788924     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.11.016     Document Type: Article

References (170)

1. Baranska S., Glinkowska M., Herman-Antosiewicz A., Maciag-Dorszynska M., Nowicki D., Szalewska-Palasz A., et al. Replicating DNA by cell factories: roles of central carbon metabolism and transcription in the control of DNA replication in microbes, and implications for understanding this process in human cells. Microb Cell Fact 2013, 12:55.
2. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
3. Koppenol W.H., Bounds P.L., Dang C.V. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011, 11:325-337.
4. Janniere L., Canceill D., Suski C., Kanga S., Dalmais B., Lestini R., et al. Genetic evidence for a link between glycolysis and DNA replication. PLoS ONE 2007, 2:e447.
5. Maciag M., Nowicki D., Janniere L., Szalewska-Palasz A., Wegrzyn G. Genetic response to metabolic fluctuations: correlation between central carbon metabolism and DNA replication in Escherichia coli. Microb Cell Fact 2011, 10:19.
6. Maciag-Dorszynska M., Ignatowska M., Janniere L., Wegrzyn G., Szalewska-Palasz A. Mutations in central carbon metabolism genes suppress defects in nucleoid position and cell division of replication mutants in Escherichia coli. Gene 2012, 503:31-35.
7. Loeb L.A., Loeb K.R., Anderson J.P. Multiple mutations and cancer. Proc Natl Acad Sci USA 2003, 100:776-781.
8. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 2004, 4:891-899.
9. Maciag M., Nowicki D., Szalewska-Palasz A., Wegrzyn G. Central carbon metabolism influences fidelity of DNA replication in Escherichia coli. Mutat Res 2012, 731:99-106.
10. Wegrzyn A., Wegrzyn G. Inheritance of the replication complex: a unique or common phenomenon in the control of DNA replication?. Arch Microbiol 2001, 175:86-93.
11. Scholefield G., Veening J.W., Murray H. DnaA and ORC: more than DNA replication initiators. Trends Cell Biol 2011, 21:188-194.
12. Mechali M. Eukaryotic DNA replication origins: many choices for appropriate answers. Nat Rev Mol Cell Biol 2010, 11:728-738.
13. Sequeira-Mendes J., Diaz-Uriarte R., Apedaile A., Huntley D., Brockdorff N., Gomez M. Transcription initiation activity sets replication origin efficiency in mammalian cells. PLoS Genet 2009, 5:e1000446.
14. Valenzuela M.S., Chen Y., Davis S., Yang F., Walker R.L., Bilke S., et al. Preferential localization of human origins of DNA replication at the 5'-ends of expressed genes and at evolutionarily conserved DNA sequences. PLoS ONE 2011, 6:e17308.
15. Taylor K., Wegrzyn G. Replication of coliphage lambda DNA. FEMS Microbiol Rev 1995, 17:109-119.
16. Szambowska A., Pierechod M., Wegrzyn G., Glinkowska M. Coupling of transcription and replication machineries in λ DNA replication initiation: evidence for direct interaction of Escherichia coli RNA polymerase and the λO protein. Nucleic Acids Res 2011, 39:168-177.
17. Olszewski P., Szambowska A., Baranska S., Narajczyk M., Wegrzyn G., Glinkowska M. A dual promoter system regulating λ DNA replication initiation. Nucleic Acids Res 2014, 42:4450-4462.
18. Ronai Z. Glycolytic enzymes as DNA binding proteins Int. J Biochem 1993, 25:1073-1076.
19. Poveda A.M., Le Clech M., Pasero P. Transcription and replication: breaking the rules of the road causes genomic instability. Transcription 2010, 1:99-102.
20. Lenzen S. A fresh view of glycolysis and glucokinase regulation: history and current status. J Biol Chem 2014, 289:12189-12194.
21. Wilson J.E. Hexokinases. Rev Physiol Biochem Pharmacol 1995, 126:65-198.
22. Wilson J.E. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 2003, 206:2049-2057.
23. Cardenas M.L., Cornish-Bowden A., Ureta T. Evolution and regulatory role of the hexokinases. Biochim Biophys Acta 1998, 1401:242-264.
24. Pedersen P.L., Mathupala S., Rempel A., Geschwind J.F., Ko Y.H. Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta 2002, 1555:14-20.
25. Sebastian S., Edassery S., Wilson J.E. The human gene for the type III isozyme of hexokinase: structure, basal promoter, and evolution. Arch Biochem Biophys 2001, 395:113-120.
26. Wolf A., Agnihotri S., Munoz D., Guha A. Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme. Neurobiol Dis 2011, 44:84-91.
27. Mathupala S.P., Ko Y.H., Pedersen P.L. Hexokinase II: cancer's doubleedged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 2006, 25:4777-4786.
28. Chen J., Zhang S., Li Y., Tang Z., Kong W. Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma. Tumor Biol 2014, 35:3743-3753.
29. Shoshan-Barmatz V., Zakar M., Rosenthal K., Abu-Hamad S. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase. Biochim Biophys Acta 2009, 1787:421-430.
30. Azoulay-Zohar H., Israelson A., Abu-Hamad S., Shoshan-Barmatz V. In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem J 2004, 377:347-355.
31. Rosano C. Molecular model of hexokinase binding to the outer mitochondrial membrane porin (VDAC1): implication for the design of new cancer therapies. Mitochondrion 2011, 11:513-519.
32. Wyatt E., Wu R., Rabeh W., Park H.W., Ghanefar M., Ardehali H. Regulation and cytoprotective role of hexokinase III. PLoS ONE 2010, 5:e13823.
33. Herrero P., Martinez-Campa C., Moreno F. The hexokinase 2 protein participates in regulatory DNA-protein complexes necessary for glucose repression of the SUC2 gene in Saccharomyces cerevisiae. FEBS Lett 1998, 434:71-76.
34. Watanabe H., Takehana K., Date M., Shinozaki T., Raz A. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res 1996, 56:2960-2963.
35. Chaput M., Claes V., Portetelle D., Cludts I., Cravador A., Burny A., et al. The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature 1988, 332:454-455.
36. Faik P., Walker J.I., Redmill A.A., Morgan M.J. Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3' sequences. Nature 1988, 332:455-457.
37. Funasaka T., Hu H., Yanagawa T., Hogan V., Raz A. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells. Cancer Res 2007, 67:4236-4238.
38. Niinaka Y., Harada K., Fujimuro M., Oda M., Haga A., Hosoki M., et al. Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis. Cancer Res 2010, 70:9483-9493.
39. Rengaraj D., Lee S.I., Yoo M., Kim T.H., Song G., Han J.Y. Expression and knockdown analysis of glucose phosphate isomerase in chicken primordial germ cells. Biol Reprod 2012, 57:1-12.
40. Raben N., Exelbert R., Spiegel R., Sherman J.B., Nakajima H., Plotz P., et al. Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency. Am J Hum Genet 1995, 56:131-141.
41. Van Schaftingen E., Jett M., Hue L., Hers H.G. Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors. Proc Natl Acad Sci USA 1981, 78:3483-3486.
42. Hirata T., Kato M., Okamura N., Fukasawa M., Sakakibara R. Expression of human placental-type 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase in various cells and cell lines. Biochem Biophys Res Commun 1998, 242:680-684.
43. Atsumi T., Chesney J., Metz C., Leng L., Donnelly S., Makita Z., et al. High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res 2002, 62:5881-5887.
44. Dalmau M., Bartrons R., Gil J. Control of fructose 2,6-bisphosphate metabolism by different mitogenic signals in Swiss 3T3 fibroblasts. Exp Cell Res 1994, 212:93-96.
45. Calvo M.N., Bartronsa R., Castanoc E., Peralesb J.C., Navarro-Sabatea A., Manzanoa A. PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells. FEBS Lett 2006, 580:3308-3314.
46. Shim H., Chun Y., Lewis B., Dang C. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc Natl Acad Sci USA 1998, 95:1511-1516.
47. Yi W., Clark P.M., Mason D.E., Keenan M.C., Hill C., Goddard W.A., et al. PFK1 glycosylation is a key regulator of cancer cell growth and central metabolic pathways. Science 2012, 337:975-980.
48. Telang S., Yalcin A., Clem A.L., Bucala R., Lane A.N., Eaton J.W., et al. Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene 2006, 25:7225-7234.
49. Yalcin A., Clem B.F., Simmons A., Lane A., Nelson K., Clem A.L., et al. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem 2009, 284:24223-24232.
50. Penhoet E.E., Kochman M., Rutter W.J. Isolation of fructose diphosphate aldolases A, B, and C. Biochemistry 1969, 8:4391-4395.
51. Ronai Z., Robinson R., Rutberg S., Lazarus P., Sardana M. Aldolase-DNA interactions in a SEWA cell system. Biochim Biophys Acta 1992, 1130:20-28.
52. Mamczur P., Mazurek J., Rakus D. Ubiquitous presence of gluconeogenic regulatory enzyme, fructose-1,6-bisphosphatase, within layers of rat retina. Cell Tissue Res 2010, 341:213-221.
53. Mamczur P., Gamian A., Kolodziej J., Dziegiel P., Rakus D. Nuclear localization of aldolase A correlates with cell proliferation. Biochim Biophys Acta 2013, 1833:2812-2822.
54. Ritterson Lew C., Tolan D.R. Targeting of several glycolytic enzymes using RNA interference reveals aldolase affects cancer cell proliferation through a non-glycolytic mechanism. J Biol Chem 2012, 287:42554-42563.
55. Mande S.C., Mainfroid V., Kalk K.H., Goraj K., Martial J.S., Hol W.G.J. Crystal structure of recombinant human triosephosphate isomerase at 2.8Å resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme. Protein Sci 1994, 3:810-821.
56. Schneider A.S. Triosephosphate isomerase deficiency: historical perspectives and molecular aspects. Baillieres Best Pract Res Clin Haematol 2000, 13:119-140.
57. Gruning N.M., Du D., Keller M.A., Luisi B.F., Ralser M. Inhibition of triosephosphate isomerase by phosphoenolpyruvate in the feedback-regulation of glycolysis. Open Biol 2014, 4:130232.
58. Ralser M., Heeren G., Breitenbach M., Lehrach H., Krobitsch S. Triose phosphate isomerase deficiency is caused by altered dimerization-not catalytic inactivity-of the mutant enzymes. PLoS ONE 2006, 1:e30.
59. Ralser M., Wamelink M.M., Kowald A., Gerisch B., Heeren G., Struys E.A., et al. Dynamic rerouting of the carbohydrate flux is key to counteracting oxidative stress. J Biol 2007, 6:10.
60. Sirover M.A. Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology. J Cell Biochem 1997, 66:133-140.
61. Nicholls C., Li H., Liu J.P. GAPDH: a common enzyme with uncommon functions. Clin Exp Pharmacol Physiol 2011, 39:674-679.
62. Scopes R.K., Stoter A. Purification of all glycolytic enzymes from one muscle extract. Methods Enzymol 1982, 90:479-490.
63. Sunaga K., Takahashi H., Chuang D.M., Ishitani R. Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibodies against amyloid plaques from Alzheimer's brain. Neurosci Lett 1995, 200:133-136.
64. Ishitani R., Sunaga K., Tanaka M., Aishita H., Chuang D.M. Overexpression of glyceraldehyde-3-phosphate dehydrogenase is involved in low Kţ-induced apoptosis in cultured cerebellar neurones. Mol Pharmacol 1997, 51:542-550.
65. Carujo S., Estanyol J.M., Ejarque A., Agell N., Bachs O., Pujol M.J. Glyceraldehyde 3- phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity. Oncogene 2006, 25:4033-4042.
66. Baxi M.D., Vishwanatha J.K. Uracil DNA glycosylase/glyceraldehyde-3-phosphate dehydrogenase is an Ap4A binding protein. Biochemistry 1995, 34:9700-9707.
67. Lee K.A., Sirover M.A. Physical association of base excision repair enzymes with parental and replicating DNA in BHK-21 cells. Cancer Res 1989, 49:3037-3044.
68. Harada N., Yasunaga R., Higashimura Y., Yamaji R., Fujimoto K., Moss J., et al. Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional activity of androgen receptor in prostate cancer cells. J Biol Chem 2007, 282:22651-22661.
69. Azam S., Jouvet N., Jilani A., Vongsamphanh R., Yang X., Yang S., et al. Human glyceraldehyde-3-phosphate dehydrogenase plays a direct role in reactivating oxidized forms of the DNA repair enzyme APE1. J Biol Chem 2008, 283:30632-30641.
70. Dai R.P., Yu F.X., Goh S.R., Chng H.W., Tan Y.L., Fu J.L., et al. Histone 2B (H2B) expression is confined to a proper NAD+/NADH redox status. J Biol Chem 2008, 283:26894-26901.
71. McKnight S. Gene switching by metabolic enzymes - how did you get on the invitation list?. Cell 2003, 114:150-152.
72. Zheng L., Roeder R.G., Luo Y. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell 2003, 114:255-266.
73. Sirover M.A. On the functional diversity of glyceraldehyde-3 phosphate dehydrogenase: biochemical mechanisms and regulatory control. Biochim Biophys Acta 2011, 1810:741-751.
74. Nagy E., Rigby W.F. Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD+-binding region (Rossmann fold). J Biol Chem 1995, 270:2755-2763.
75. Arutyunova E.I., Danshina P.V., Domnina L.V., Pleten A.P., Muronetz V.I. Oxidation of glyceraldehyde-3-phosphate dehydrogenase enhances its binding to nucleic acids. Biochem Biophys Res Commun 2003, 307:547-552.
76. Hwang N.R., Yim S.H., Kim Y.M., Jeong J., Song E.J., Lee Y., et al. Oxidative modifications of glyceraldehyde-3-phosphate dehydrogenase play a key role in its multiple cellular functions. Biochem J 2009, 423:253-264.
77. Meyer-Siegler K., Mauro D.J., Seal G., Wurzer J., deRiel J.K., Sirover M.A. A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci USA 1991, 88:8460-8464.
78. Nicholls C., Pinto A.R., Li H., Li L., Wang L., Simpson R., et al. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) induces cancer cell senescence by interacting with telomerase RNA component. Proc Natl Acad Sci USA 2012, 109:13308-13313.
79. McCarrey J.R., Thomas K. Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene. Nature 1987, 326:501-505.
80. Wang J., Dai J., Jung Y., Wei C.L., Wang Y., Havens A.M., et al. A glycolytic mechanism regulating an angiogenic switch in prostate cancer. Cancer Res 2007, 67:149-159.
81. Popanda O., Fox G., Thielmann H.W. Modulation of DNA polymerases α, δ and ε by lactate dehydrogenase and 3-phosphoglycerate kinase. Biochim Biophys Acta 1998, 1397:102-117.
82. Zieker D. Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer. Int J Cancer 2010, 126:1513-1520.
83. Vishwanatha J.K., Jindal H.K., Davis R.G. The role of primer recognition proteins in DNA replication: association with nuclear matrix in HeLa cells. J Cell Sci 1992, 101:25-34.
84. Accorsi A., Piatti E., Piacentini M.P., Gini S., Fazi A. Isoenzymes of phosphoglucomutase from human red blood cells: isolation and kinetic properties. Prep Biochem 1989, 19:251-271.
85. Kondoh H., Lleonart M.E., Gil J., Wang J., Degan P., Peters G., et al. Glycolytic enzymes can modulate cellular life span. Cancer Res. 2005, 65:177-185.
86. Hitosugi T., Zhou L., Elf S., Fan J., Kang H.B., Hoseo J., et al. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell 2012, 22:585-600.
87. Piast M., Kustrzeba-Wojcicka I., Matusiewicz M., Banas T. Molecular evolution of enolase. Acta Biochim Pol 2005, 52:507-513.
88. Feo S., Arcuri D., Piddini E., Passantino R., Giallongo A. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc romoter binding protein 1 (MBP-1). FEBS Lett 2000, 473:47-52.
89. Wang W., Wang L., Endoh A., Hummelke G., Hawks C.L., Hornsby P.J. Identification of α-enolase as a nuclear DNA-binding protein in the zona fasciculata but not the zona reticularis of the human adrenal cortex. J Endocrinol 2005, 184:85-94.
90. Hamaguchi T., Iizuka N., Tsunedomi R., Hamamoto Y., Miyamoto T., Iida M., et al. Glycolysis module activated by hypoxia-inducible factor 1α is related to the aggressive phenotype of hepatocellular carcinoma. Int J Oncol 2008, 33:725-731.
91. Holland J.P., Labieniec L., Swimmer C., Holland M.J. Homologous nucleotide sequences at the 5' termini of messenger RNAs synthesized from the yeast enolase and glyceraldehyde-3-phosphate dehydrogenase gene families. The primary structure of a third yeast glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 1983, 258:5291-5299.
92. Diaz-Ramos A., Roig-Borrellas A., Garcia-Melero A., Lopez-Alemany R. Α-enolase, a multifunctional protein: its role on pathophysiological situations. J Biomed Biotechnol 2012, 2012:156795.
93. Tsai S.T., Chien I.H., Shen W.H., Kuo Y.Z., Jin Y.T., Wong T.Y., et al. ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. Eur J Cancer 2010, 46:1712-1723.
94. Rinehart J., Krett B., Rubio M.A., Alfonzo J.D., Söll D. Saccharomyces cerevisiae imports the cytosolic pathway for Gln-tRNA synthesis into the mitochondrion. Genes Dev 2005, 19:583-592.
95. Martin R.P., Schneller J.M., Stahl A.J., Dirheimer G. Import of nuclear deoxyribonucleic acid coded lysine accepting transfer ribonucleic acid (anticodon C-U-U) into yeast mitochondria. Biochemistry 1979, 18:4600-4605.
96. Entelis N., Brandina I., Kamenski P., Krasheninnikov I.A., Martin R.P., Tarassov I. A glycolytic enzyme, enolase, is recruited as a cofactor of tRNA targeting toward mitochondria in Saccharomyces cerevisiae. Genes Dev 2006, 20:1609-1620.
97. al-Giery A.G., Brewer J.M. Characterization of the interaction of yeast enolase with polynucleotides. Biochim Biophys Acta 1992, 1159:134-140.
98. Edwards S.R., Braley R., Chaffin W.L. Enolase is present in the cell wall of Saccharomyces cerevisiae. FEMS Microbiol Lett 1999, 177:211-216.
99. Morita T., Kawamoto H., Mizota T., Inada T., Aiba H. Enolase in the RNA degradosome plays a crucial role in the rapid decay of glucose transporter mRNA in the response to phosphosugar stress in Escherichia coli. Mol Microbiol 2004, 54:1063-1075.
100. Wong N., De Melo J., Tang D. PKM2, a central point of regulation in cancer metabolism. Int J Cell Biol 2013, 2013:242513.
101. Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
102. Mazurek S., Boschek C.B., Eigenbrodt E. The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy. J Bioenerg Biomembr 1997, 29:315-330.
103. Mazurek S., Boschek C.B., Hugo F., Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 2005, 15:300-308.
104. Gao X., Wang H., Yang J.J., Liu X., Liu Z.R. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell 2012, 45:598-609.
105. Eigenbrodt E., Reinacher M., Scheefers-Borchel U., Scheefers H., Friis R. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit Rev Oncog 1992, 3:91-115.
106. Gruning N.M., Rinnerthaler M., Bluemlein K., Mülleder M., Wamelink M.M.C., Lehrach H., et al. Pyruvate kinase triggers a metabolic feedback loop that controls redox metabolism in respiring cells. Cell Metab 2011, 14:415-427.
107. Spoden G.A., Rostek U., Lechner S., Mitterberger M., Mazurek S., Zwerschke W. Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply. Exp Cell Res 2009, 315:2765-2774.
108. Yang W., Xia Y., Ji H., Zheng Y., Liang J., Huang W., et al. Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation. Nature 2011, 480:118-122.
109. Lu Z. PKM2 functions as a histone kinase. Cell Cycle 2012, 11:4101-4102.
110. Goldberg M.S., Sharp P.A. Pyruvate kinase M2 specific siRNA induces apoptosis and tumor regression. J Exp Med 2012, 209:217-224.
111. Emmerling M., Dauner M., Ponti A., Fiaux J., Hochuli M., Szyperski T., et al. Metabolic flux responses to pyruvate kinase knockout in Escherichia coli. J Bacteriol 2002, 184:152-164.
112. Anastasiou D., Poulogiannis G., Asara J.M., Boxer M.B., Jiang J.K., Shen M., et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 2011, 334:1278-1283.
113. Granchi C., Bertini S., Macchia M., Minutolo F. Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials. Curr Med Chem 2010, 17:672-697.
114. Pioli P.A., Hamilton B.J., Connolly J.E., Brewer G., Rigby W.F. Lactate dehydrogenase is an AU-rich element-binding protein that directly interacts with AUF1. J Biol Chem 2002, 277:35738-35745.
115. Rong Y., Wu W., Ni X., Kuang T., Jin D., Wang D., et al. Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumor Biol 2013, 34:1523-1530.
116. Sheng S.L., Liu J.J., Dai Y.H., Sun X.G., Xiong X.P., Huang G. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma. FEBS J 2012, 279:3898-3910.
117. Zhai X., Yang Y., Wan J., Zhu R., Wu Y. Inhibition of LDH-A by oxamate induces G2/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells. Oncol Rep 2013, 30:2983-2991.
118. Nunes-Nesi A., Araujo W.L., Obata T., Fernie A.R. Regulation of the mitochondrial tricarboxylic acid cycle. Curr Opin Plant Biol 2013, 16:335-343.
119. Kim K.S., Rosenkrantz M.S., Guarente L. Saccharomyces cerevisiae contains two functional citrate synthase genes. Mol Cell Biol 1986, 6:1936-1942.
120. Velot C., Lebreton S., Morgunov I., Usher K.C., Srere P.A. Metabolic effects of mislocalized mitochondrial and peroxisomal citrate synthases in yeast Saccharomyces cerevisiae. Biochemistry 1999, 38:16195-16204.
121. Lee Y.J., Hoe K.L., Maeng P.J. Yeast cells lacking the CIT1-encoded mitochondrial citrate synthase are hypersusceptible to heat- or aging-induced apoptosis. Mol Biol Cell 2007, 18:3556-3567.
122. Krebs H.A., Lowenstain J. The tricarboxylic acid cycle. Metabolic pathways 1960, Academic Press Inc., New York. D.M. Greenberg (Ed.).
123. Lin C.C., Cheng T.L., Tsai W.H., Tsai H.J., Hu K.H., Chang H.C., et al. Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy. Sci Rep 2012, 2:785.
124. Ghneim H.K., Al-Sheikh Y.A. The effect of aging and increasing ascorbate concentrations on respiratory chain activity in cultured human fibroblasts. Cell Biochem Funct 2010, 28:283-292.
125. 2. J Neurochem 2011, 18:79-92.
126. 2-mediated neurotoxicity in rat primary mesencephalic cultures. PLoS ONE 2009, 4:e7095.
127. Przybyla-Zawislak B., Gadde D.M., Ducharme K., McCammon M.T. Genetic and biochemical interactions involving tricarboxylic acid cycle (TCA) function using a collection of mutants defective in all TCA cycle genes. Genetics 1999, 152:1153-1166.
128. Ternette N., Yang M., Laroyia M., Kitagawa M., O'Flaherty L., Wolhulter K., et al. Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency. Cell Rep 2013, 3:689-700.
129. Reitman Z.J., Yan H. Isocitrate dehydrogenase 1 and 2 mutations in cancer: alternations at a crossroads of cellular metabolism. J Natl Cancer Inst 2010, 102:932-940.
130. Geisbrecht B.V., Gould S.J. The human PICD gene encodes a cytoplasmic and peroxisomal NADP(+)-dependent isocitrate dehydrogenase. J Biol Chem 1999, 274:30527-30533.
131. Minard K.I., McAlister-Henn L. Dependence of peroxisomal beta-oxidation on cytosolic sources of NADPH. J Biol Chem 1999, 274:3402-3406.
132. Nekrutenko A., Hillis D.M., Patton J.C., Bradley R.D., Baker R.J. Cytosolic isocitrate dehydrogenase in humans, mice, and voles and phylogenetic analysis of the enzyme family. Mol Biol Evol 1998, 15:1674-1684.
133. Lemons J.M., Feng X.J., Bennett B.D., Legesse-Miller A., Johnson E.L., Raitman I., et al. Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol 2010, 8:e1000514.
134. Krell D., Assoku M., Galloway M., Mulholland P., Tomlinson I., Bardella C. Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma. PLoS ONE 2011, 6:e19868.
135. Roermund C.W., Hettema E.H., Kal A.J., van den Berg M., Tabak H.F., Wanders R.J. Peroxisomal beta-oxidation of polyunsaturated fatty acids in Saccharomyces cerevisiae: isocitrate dehydrogenase provides NADPH for reduction of double bonds at even positions. EMBO J 1998, 17:677-687.
136. Lee S.M., Koh H.J., Park D.C., Song B.J., Huh T.L., Park J.W. Cytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radical Biol Med 2002, 32:1185-1196.
137. Sheu K.F., Blass J.P. The α-ketoglutarate dehydrogenase complex. Ann N Y Acad Sci 1999, 893:61-78.
138. Szabo P., Cai X., Ali G., Blass J.P. Localization of the gene (OGDH) coding for the E1k component of the alpha-ketoglutarate dehydrogenase complex to chromosome 7p13-p11.2. Genomics 1994, 20:324-326.
139. Tylicki A., Czerniecki J., Dobrzyn P., Matanowska A., Olechno A., Strumilo S. Modification of thiamine pyrophosphate dependent enzyme activity by oxythiamine in Saccharomyces cerevisiae cells. Can J Microbiol 2005, 51:833-839.
140. Bunik V.I., Degtyarev D. Structure-function relationships in the 2-oxo acid dehydrogenase family: substrate-specific signatures and functional predictions for the 2-oxoglutarate dehydrogenase-like proteins. Proteins 2008, 71:874-890.
141. Sen T., Sen N., Noordhuis M.G., Ravi R., Wu T.C., Ha P.K., et al. OGDHL is a modifier of AKT-dependent signaling and NF-κB function. PLoS ONE 2012, 7:e48770.
142. Johnson J.D., Mehus J.G., Tews K., Milavetz B.I., Lambeth D.O. Genetic evidence for the expression of ATP- and GTP-specific succinyl-CoA synthetases in multicellular eucaryotes. J Biol Chem 1998, 273:27580-27586.
143. Miller C., Wang L., Ostergaard E., Dan P., Saada A. The interplay between SUCLA2, SUCLG2, and mitochondrial DNA depletion. Biochim Biophys Acta 2011, 1812:625-629.
144. Scheffler I.E. Molecular genetics of succinate: quinone oxidoreductase in eukaryotes Prog. Nucleic Acid Res Mol Biol 1998, 60:267-315.
145. Baysal B.E., Ferrell R.E., Willett-Brozick J.E., Lawrence E.C., Myssiorek D., Bosch A., et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000, 287:848-851.
146. Lee S., Nakamura E., Yang H., Wei W., Linggi M.S., Sajan M.P., et al. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 2005, 8:155-167.
147. Guzy R.D., Sharma B., Bell E., Chandel N.S., Schumacker P.T. Loss of the SdhB, but not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol Cell Biol 2008, 28:718-731.
148. Slane B.G., Aykin-Burns N., Smith B.J., Kalen A.L., Goswami P.C., Domann F.E., et al. Mutation of succinate dehydrogenase subunit C results in increased O2.-, oxidative stress, and genomic instability. Cancer Res 2006, 66:7615-7620.
149. Gimenez-Roqueplo A.P., Favier J., Rustin P., Mourad J.J., Plouin F.F., Corvol P., et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet 2001, 69:1186-1197.
150. Cervera A.M., Bayley J.P., Devilee P., McCreath K.J. Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells. Mol Cancer 2009, 8:89.
151. Stein I., Peleg Y., Even-Ram S., Pines O. The single translation product of the FUM1 gene (fumarase) is processed in mitochondria before being distributed between the cytosol and mitochondria in Saccharomyces cerevisiae. Mol Cell Biol 1994, 14:4770-4778.
152. Ravdin R.G., Crandall D.I. The enzymatic conversion of homogentisic acid to 4-fumarylacetoacetic acid. J Biol Chem 1951, 189:137-149.
153. Ratner S., Anslow W.P., Petrack B. Biosynthesis of urea VI enzymatic cleavage of argininosuccinic acid to arginine and fumaric acid. J Biol Chem 1953, 204:115-125.
154. Yogev O., Naamati A., Pines O. Fumarase: a paradigm of dual targeting and dual localized functions. FEBS J 2011, 278:4230-4242.
155. Yogev O., Yogev O., Singer E., Shaulian E., Goldberg M., Fox T.D., et al. Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol 2010, 8:e1000328.
156. Ling T.S., Shi R.H., Zhang G.X., Zhu H., Yu L.Z., Ding X.F. Common single nucleotide polymorphism of hypoxia-inducible factor-1α and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin J Dig Dis 2005, 6:155-158.
157. Selak M.A., Armour S.M., MacKenzie E.D., Boulahbel H., Watson D.G., Mansfield K.D., et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 2005, 7:77-85.
158. 2 sensing. Science 2001, 292:464-468.
159. 2-regulated prolyl hydroxylation. Science 2001, 292:468-472.
160. Raimundo N., Baysal B.E., Shadel G.S. Revisiting the TCA cycle: signaling to tumor formation. Trends Mol Med 2011, 17:641-649.
161. Cardaci S., Ciriolo M.R. TCA cycle defects and cancer: when metabolism tunes redox state. Int J Cell Biol 2012, 2012:1-9.
162. Poeydomenge O., Marolda M., Boudet A.M., Grima-Pettenati J. Nucleotide sequence of a cDNA encoding mitochondrial malate dehydrogenase from Eucalyptus. Plant Physiol 1995, 107:1455-1456.
163. Webb L.E., Hill E.J., Banaszak L.J. Conformation of nicotinamide adenine dinucleotide bound to cytoplasmic malate dehydrogenase. Biochemistry 1973, 12:5101-5109.
164. Lee S.M., Kim J.H., Cho E.J., Youn H.D. A nucleocytoplasmic malate dehydrogenase regulates p53 transcriptional activity in response to metabolic stress. Cell Death Differ 2009, 16:738-748.
165. Lee S.M., Dho S.H., Ju S.K., Maeng J.S., Kim J.Y., Kwon K.S. Cytosolic malate dehydrogenase regulates senescence in human fibroblasts. Biogerontology 2012, 13:525-536.
166. Grant P.M., Roderick S.L., Grant G.A., Banaszak L.J., Strauss A.W. Comparison of the precursor and mature forms of rat heart mitochondrial malate dehydrogenase. Biochemistry 1987, 26:128-134.
167. Lo A.S., Liew C.T., Ngai S.M., Tsui S.K., Fung K.P., Lee C.Y., et al. Developmental regulation and cellular distribution of human cytosolic malate dehydrogenase (MDH1). J Cell Biochem 2005, 94:763-773.
168. Kim J.W., Dang C.V. Multifaceted roles of glycolytic enzymes. Trends Biochem Sci 2005, 30:142-150.
169. Petrak J., Ivanek R., Toman O., Cmejla R., Cmejlova J., Vyoral D., et al. Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 2008, 8:1744-1749.
170. Capello M., Ferri-Borgognno S., Cappello P., Novelli F. α-Enolase: a promising therapeutic and diagnostic tumor target. FEBS J 2011, 278:1064-1074.